Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (181-190 of 266) with videos related to

Pageof 27
Sort By:
Scientific Reports|October 24, 2024
Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional studyRui Bernardino, Ana Sofia Carvalho, Michael J Hall, et al.
BJU International|November 15, 2008
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancerAbbas H Panju, Henriette Breunis, Angela M Cheung, et al.
World Journal of Urology|November 28, 2024
Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?Rui M Bernardino, Leyi B Yin, Katherine Lajkosz, et al.
BJU International|November 28, 2024
Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mLSamuel Sii, Nathan Papa, Ting Wai Yiu, et al.
Urologic Oncology|January 13, 2023
Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillanceGuan Hee Tan, Dominik Deniffel, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 21, 2025
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update)Alan I So, Kim Chi, Brita Danielson, et al.
Journal of Physical Activity & Health|November 6, 2021
The Relationship Between Preoperative Physical Activity With American Society of Anesthesiologists Score and Postoperative Length of Stay in Patients Undergoing Radical ProstatectomyEfthymios Papadopoulos, Priya Brahmbhatt, Shabbir M H Alibhai, et al.
European Radiology|May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsyDominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
The Journal of Urology|March 20, 2020
Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseaseWei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
European Urology|November 12, 2019
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-upLaurence Klotz, Greg Pond, Andrew Loblaw, et al.
Pageof 27

Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
Scientific Reports|October 24, 2024
Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional studyRui Bernardino, Ana Sofia Carvalho, Michael J Hall, et al.
BJU International|November 15, 2008
Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancerAbbas H Panju, Henriette Breunis, Angela M Cheung, et al.
World Journal of Urology|November 28, 2024
Can the free/total psa ratio predict undetected intraductal carcinoma and cribriform pattern at biopsy?Rui M Bernardino, Leyi B Yin, Katherine Lajkosz, et al.
BJU International|November 28, 2024
Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mLSamuel Sii, Nathan Papa, Ting Wai Yiu, et al.
Urologic Oncology|January 13, 2023
Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillanceGuan Hee Tan, Dominik Deniffel, Antonio Finelli, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 21, 2025
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update)Alan I So, Kim Chi, Brita Danielson, et al.
Journal of Physical Activity & Health|November 6, 2021
The Relationship Between Preoperative Physical Activity With American Society of Anesthesiologists Score and Postoperative Length of Stay in Patients Undergoing Radical ProstatectomyEfthymios Papadopoulos, Priya Brahmbhatt, Shabbir M H Alibhai, et al.
European Radiology|May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsyDominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
The Journal of Urology|March 20, 2020
Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive DiseaseWei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
European Urology|November 12, 2019
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-upLaurence Klotz, Greg Pond, Andrew Loblaw, et al.
Pageof 27